軟骨形成不全の

関: achondroplasia、chondrodysplasia、dyschondroplasia

WordNet

of or relating to achondroplasia
an inherited skeletal disorder beginning before birth; cartilage is converted to bone resulting in dwarfism (同)achondroplasty, osteosclerosis congenita, chondrodystrophy

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/11/01 01:49:14」(JST)

wiki en

Achondroplasia is a common cause of dwarfism. It occurs as a sporadic mutation in approximately 80% of cases (associated with advanced paternal age) or it may be inherited as an autosomal dominant genetic disorder.

People with achondroplasia have short stature, with an average adult height of 131 centimeters (52 inches) for males and 123 centimeters (48 inches) for females. Achondroplastic adults are known to be as short as 62.8 cm (24.7 in). If both parents of a child have achondroplasia, and both parents pass on the mutant gene, then it is very unlikely that the homozygous child will live past a few months of its life. The prevalence is approximately 1 in 25,000.^[3]

Play media

Video explanation

Signs and symptoms

Detail of Las Meninas by Diego Velázquez (1656), showing Maribarbola and Nicolasito Pertusato (right), achondroplastic dwarfs in the entourage of Infanta Margarita

Disproportionate dwarfism
Shortening of the proximal limbs (called rhizomelic shortening)
Short fingers and toes with trident hands
Large head with prominent forehead frontal bossing
Small midface with a flattened nasal bridge
Spinal kyphosis (convex curvature) or lordosis (concave curvature)
Varus (bowleg) or valgus (knock knee) deformities
Frequently have ear infections (due to Eustachian tube blockages), sleep apnea (which can be central or obstructive), and hydrocephalus

Causes

Achondroplasia is caused by a mutation in fibroblast growth factor receptor 3 (FGFR3). In normal development FGFR3 has a negative regulatory effect on bone growth. In achondroplasia, the mutated form of the receptor is constitutively active and this leads to severely shortened bones. The effect is genetically dominant, with one mutant copy of the FGFR3 gene being sufficient to cause achondroplasia, while two copies of the mutant gene are invariably fatal (recessive lethal) before or shortly after birth (known as a lethal allele). A person with achondroplasia thus has a 50% chance of passing dwarfism to each of their offspring. People with achondroplasia can be born to parents that do not have the condition due to spontaneous mutation.^[4]

New gene mutations leading to achondroplasia are associated with a father older than the age of 35.^[5] Studies have demonstrated that new gene mutations for achondroplasia are exclusively inherited from the father and occur during spermatogenesis; it is theorized that oogenesis has some regulatory mechanism that prevents the mutation occurring in females.^{[citation needed]}

There are two other syndromes with a genetic basis similar to achondroplasia: hypochondroplasia and thanatophoric dysplasia.

Diagnosis

Achondroplasia can be detected before birth by the use of prenatal ultrasound. A DNA test can be performed before birth to detect homozygosity, wherein two copies of the mutant gene are inherited, a lethal condition leading to stillbirths. Clinical features include megalocephaly, short limbs, prominent forehead, thoracolumbar kyphosis and mid-facial hypoplasia.^[6] Complications like dental malocclusion, hydrocephalus and repeated otitis media can be observed.^[6] The risk of death in infancy is increased due to the likelihood of compression of the spinal cord with or without upper airway obstruction.

Radiologic findings

A skeletal survey is useful to confirm the diagnosis of achondroplasia. The skull is large, with a narrow foramen magnum, and relatively small skull base. The vertebral bodies are short and flattened with relatively large intervertebral disk height, and there is congenitally narrowed spinal canal. The iliac wings are small and squared,^[7] with a narrow sciatic notch and horizontal acetabular roof. The tubular bones are short and thick with metaphyseal cupping and flaring and irregular growth plates. Fibular overgrowth is present. The hand is broad with short metacarpals and phalanges, and a trident configuration. The ribs are short with cupped anterior ends. If the radiographic features are not classic, a search for a different diagnosis should be entertained. Because of the extremely deformed bone structure, people with achondroplasia are often "double jointed".

The diagnosis can be made by fetal ultrasound by progressive discordance between the femur length and biparietal diameter by age. The trident hand configuration can be seen if the fingers are fully extended.

Another distinct characteristic of the syndrome is thoracolumbar gibbus in infancy.

Treatment

There is no known cure for achondroplasia even though the cause of the mutation in the growth factor receptor has been found. Although used by those without achondroplasia to aid in growth, human growth hormone does not help people with achondroplasia. However, if desired, the controversial surgery of limb-lengthening will lengthen the legs and arms of someone with achondroplasia.^[8]

Usually, the best results appear within the first and second year of therapy.^[9] After the second year of growth hormone therapy, beneficial bone growth decreases.^[10] Therefore, GH therapy is not a satisfactory long term treatment.^[9]

Gene based therapy may possibly serve as a future treatment option. BioMarin Pharmaceutical Inc. announced in 2012 the initiation of a Phase 1 study in healthy volunteers for vosoritide (BMN-111), an analog of C-type Natriuretic Peptide (CNP), for the treatment of achondroplasia. In June of 2015, BioMarin announced positive results of their Phase 2 study, stating that 10 children experienced a mean increase of 50% in their annualized growth velocity.^[11]

Epidemiology

Achondroplasia is one of 19 congenital conditions with similar presentations, such as osteogenesis imperfecta, multiple epiphyseal dysplasia tarda, achondrogenesis, osteopetrosis, and thanatophoric dysplasia. This makes estimates of prevalence difficult, with changing and subjective diagnostic criteria over time. One detailed and long-running study in the Netherlands found that the prevalence determined at birth was only 1.3 per 100,000 live births.^[12] Another study at the same time found a rate of 1 per 10,000.^[12]

Other animals

Based on their disproportionate dwarfism, some dog breeds traditionally have been classified as "achondroplastic." This is the case for the dachshund, basset hound, corgi and bulldog breeds.^[13]^[14]^[15] Data from whole genome association studies in short-limbed dogs reveal a strong association of this trait with a retro-gene coding for fibroblast growth factor 4 (FGF4).^[16] Therefore, it seems unlikely that dogs and humans are achondroplastic for the same reasons. However, histological studies in some achondroplastic dog breeds have shown altered cell patterns in cartilage that are very similar to those observed in humans exhibiting achondroplasia.^[17]

A similar form of achondroplasia was found in a litter of piglets from a phenotypically normal Danish sow. The dwarfism was inherited dominant in the offspring from this litter. The piglets were born phenotypically normal but became more and more symptomatic as they reached maturity.^[18] This involved a mutation of the protein Collagen, type X, alpha 1, encoded by the COL10A1 gene. In humans a similar mutation (G595E) has been associated with Schmid metaphyseal chondrodysplasia (SMCD), a relatively mild skeletal disorder that is also associated with dwarfism.

The now-extinct Ancon sheep was created by humans through the selective breeding of common domestic sheep with achondroplasia. The average-sized torso combined with the relatively smaller legs produced by achondroplasia was valued for making affected sheep less likely to escape without affecting the amount of wool or meat each sheep produced.^[19]

References

^ "Achondroplasia". Oxford Dictionaries. Oxford University Press. Retrieved 2016-01-20.
^ "Achondroplasia". Merriam-Webster Dictionary.
^ Wynn J, King TM, Gambello MJ, Waller DK, Hecht JT (2007). "Mortality in achondroplasia study: A 42-year follow-up". Am. J. Med. Genet. A. 143 (21): 2502–11. doi:10.1002/ajmg.a.31919. PMID 17879967.
^ Richette P, Bardin T, Stheneur C (2007). "Achondroplasia: From genotype to phenotype". Joint Bone Spine. 75 (2): 125–30. doi:10.1016/j.jbspin.2007.06.007. PMID 17950653.
^ Dakouane Giudicelli M, Serazin V, Le Sciellour CR, Albert M, Selva J, Giudicelli Y (2007). "Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies". Fertil Steril. 89 (6): 1651–6. doi:10.1016/j.fertnstert.2007.04.037. PMID 17706214.
^ ^a ^b Beattie, R.M.; Champion, M.P., eds. (2004). Essential questions in paediatrics for MRCPCH. (1st ed.). Knutsford, Cheshire: PasTest. ISBN 1-901198-99-5.
^ "Achondroplasia Pelvis". Archived from the original on 2007-10-22. Retrieved 2007-11-28.
^ Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N (2007). "Distraction osteogenesis of the lower extremity in patients that have achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma". J Pediatr Orthop. 27 (6): 629–34. doi:10.1097/BPO.0b013e318093f523. PMID 17717461.
^ ^a ^b Vajo, Z; Francomano, CA; Wilkin, DJ (2000). "The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.". Endocrine Reviews. 21 (1): 23–39. doi:10.1210/er.21.1.23. PMID 10696568.
^ Aviezer, D; Golembo, M; Yayon, A (2003). "Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia—genetic short limbed dwarfism.". Current drug targets. 4 (5): 353–65. doi:10.2174/1389450033490993. PMID 12816345.
^ "BioMarin Surges On Positive Results From Phase-2 Study Of Dwarfism Drug". NASDAQ.com. The NASDAQ OMX Group, Inc. Retrieved 23 June 2015.
^ ^a ^b Online 'Mendelian Inheritance in Man' (OMIM) ACHONDROPLASIA; ACH -100800
^ "WebMD".
^ Jones, T.C.; Hunt, R.D. (1979). "The musculoskeletal system". In Jones, T.C.; Hunt, R.D.; Smith, H.A. Veterinary Pathology (5th ed.). Philadelphia: Lea & Febiger. pp. 1175–6. ISBN 0812107896.
^ Willis M.B. (1989). "Inheritance of specific skeletal and structural defects". In Willis M.B. Genetics of the Dog. Great Britain: Howell Book House. pp. 119–120. ISBN 087605551X.
^ Parker HG, VonHoldt BM, Quignon P, et al. (August 2009). "An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs". Science. 325 (5943): 995–8. doi:10.1126/science.1173275. PMC 2748762. PMID 19608863.
^ Braund KG, Ghosh P, Taylor TK, Larsen LH (September 1975). "Morphological studies of the canine intervertebral disc. The assignment of the beagle to the achondroplastic classification". Res. Vet. Sci. 19 (2): 167–72. PMID 1166121.
^ Nielsen VH, Bendixen C, Arnbjerg J, et al. (December 2000). "Abnormal growth plate function in pigs carrying a dominant mutation in type X collagen". Mamm. Genome. 11 (12): 1087–92. doi:10.1007/s003350010212. PMID 11130976.
^ Gidney, Louisa (May–June 1019). "Earliest Archaeological Evidence of the Ancon Mutation in Sheep from Leicester, UK". International Journal of Osteoarchaeology. John Wiley and Son. 15 (27): 318–321. doi:10.1002/oa.872. ISSN 1099-1212.

External links

Achondroplasia at DMOZ
Pauli RM (1998). "Achondroplasia". In Pagon RA, Bird TD, Dolan CR, et al. GeneReviews. Seattle WA: University of Washington, Seattle. PMID 20301331. NBK1152.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 歯の解剖学的構造および発達 anatomy and development of the teeth

English Journal

Diagnostics and management of sleep-related respiratory disturbances in children with skeletal dysplasia caused by fgfr3 mutations (achondroplasia and hypochondroplasia).

Schluter B, De Sousa G, Trowitzsch E, Andler W.SourceSchlaflabor der Vestischen Kinder- und Jugendklinik Datteln, Universitat Witten /Herdecke.
Georgian medical news.Georgian Med News.2011 Jul-Aug;(196-197):63-72.
To evaluate the frequency of clinical indicators for sleep-related respiratory disturbances (SRD) and the polysomnographical manifestations of these disorders in children with skeletal dysplasia caused by FGFR3 mutations. From January 1990 to January 2009, 24 patients (22 achondroplasia, 2 hypochond
PMID 21873755

Effects of diadenosine tetraphosphate on FGF9-induced chloride flux changes in achondroplastic chondrocytes.

Huete F, Guzman-Aranguez A, Ortin J, Hoyle CH, Pintor J.SourceDepartamento de Bioquimica, E.U. Optica, Universidad Complutense de Madrid, c/Arcos de Jalon 118, 28037, Madrid, Spain.
Purinergic signalling.Purinergic Signal.2011 Jun;7(2):243-9. Epub 2011 May 11.
Achondroplasia, the most common type of dwarfism, is characterized by a mutation in the fibroblast growth factor receptor 3 (FGFR3). Achondroplasia is an orphan pathology with no pharmacological treatment so far. However, the possibility of using the dinucleotide diadenosine tetraphosphate (Ap(4)A)
PMID 21559786

Japanese Journal

乳児期に大後頭孔狭窄による呼吸障害と四肢麻痺が進行した軟骨無形成症の1例

宮地充,上原久輝,長谷川龍志,余玲理,坂井智行,藤井法子,内藤岳史,羽田聡,中島文明,北野昌平,坂本博昭
日本小児科学会雑誌 109(4), 523-527, 2005-04-01
NAID 10016776106

成長ホルモン療法を行った軟骨無形成症患児の耐糖能とbody mass index

宮澤真理
日本小児科学会雑誌 106(1), 46-51, 2002-01-01
NAID 10008123932

Related Pictures

★リンクテーブル★

拡張検索	「pseudoachondroplastic dysplasia」

「pseudoachondroplastic dysplasia」

Achondroplasia
	Jason "Wee Man" Acuña actor with achondroplasia
Classification and external resources
Pronunciation	/eɪˌkɒndrəˈpleɪziə, ə-, -ˈpleɪʒiə, -ˈpleɪʒə/
Specialty	Medical genetics
ICD-10	Q77.4
ICD-9-CM	756.4
OMIM	100800 134934
DiseasesDB	80
MedlinePlus	001577
eMedicine	article/1258401-overview
Patient UK	Achondroplasia
MeSH	D000130
	[edit on Wikidata]

　　[★] 偽軟骨形成不全性異形成症

[1] "Achondroplasia". Oxford Dictionaries. Oxford University Press. Retrieved 2016-01-20.

[2] "Achondroplasia". Merriam-Webster Dictionary.

[pmid17879967-3] Wynn J, King TM, Gambello MJ, Waller DK, Hecht JT (2007). "Mortality in achondroplasia study: A 42-year follow-up". Am. J. Med. Genet. A. 143 (21): 2502–11. doi:10.1002/ajmg.a.31919. PMID 17879967.

[pmid17950653-4] Richette P, Bardin T, Stheneur C (2007). "Achondroplasia: From genotype to phenotype". Joint Bone Spine. 75 (2): 125–30. doi:10.1016/j.jbspin.2007.06.007. PMID 17950653.

[pmid17706214-5] Dakouane Giudicelli M, Serazin V, Le Sciellour CR, Albert M, Selva J, Giudicelli Y (2007). "Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies". Fertil Steril. 89 (6): 1651–6. doi:10.1016/j.fertnstert.2007.04.037. PMID 17706214.

[BeattieChampion2004-6] Beattie, R.M.; Champion, M.P., eds. (2004). Essential questions in paediatrics for MRCPCH. (1st ed.). Knutsford, Cheshire: PasTest. ISBN 1-901198-99-5.

[titleAchondroplasia_Pelvis-7] "Achondroplasia Pelvis". Archived from the original on 2007-10-22. Retrieved 2007-11-28.

[pmid17717461-8] Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N (2007). "Distraction osteogenesis of the lower extremity in patients that have achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma". J Pediatr Orthop. 27 (6): 629–34. doi:10.1097/BPO.0b013e318093f523. PMID 17717461.

[ReferenceA-9] Vajo, Z; Francomano, CA; Wilkin, DJ (2000). "The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.". Endocrine Reviews. 21 (1): 23–39. doi:10.1210/er.21.1.23. PMID 10696568.

[10] Aviezer, D; Golembo, M; Yayon, A (2003). "Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia—genetic short limbed dwarfism.". Current drug targets. 4 (5): 353–65. doi:10.2174/1389450033490993. PMID 12816345.

[11] "BioMarin Surges On Positive Results From Phase-2 Study Of Dwarfism Drug". NASDAQ.com. The NASDAQ OMX Group, Inc. Retrieved 23 June 2015.

[OMIM-12] Online 'Mendelian Inheritance in Man' (OMIM) ACHONDROPLASIA; ACH -100800

[13] "WebMD".

[14] Jones, T.C.; Hunt, R.D. (1979). "The musculoskeletal system". In Jones, T.C.; Hunt, R.D.; Smith, H.A. Veterinary Pathology (5th ed.). Philadelphia: Lea & Febiger. pp. 1175–6. ISBN 0812107896.

[15] Willis M.B. (1989). "Inheritance of specific skeletal and structural defects". In Willis M.B. Genetics of the Dog. Great Britain: Howell Book House. pp. 119–120. ISBN 087605551X.

[16] Parker HG, VonHoldt BM, Quignon P, et al. (August 2009). "An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs". Science. 325 (5943): 995–8. doi:10.1126/science.1173275. PMC 2748762. PMID 19608863.

[17] Braund KG, Ghosh P, Taylor TK, Larsen LH (September 1975). "Morphological studies of the canine intervertebral disc. The assignment of the beagle to the achondroplastic classification". Res. Vet. Sci. 19 (2): 167–72. PMID 1166121.

[18] Nielsen VH, Bendixen C, Arnbjerg J, et al. (December 2000). "Abnormal growth plate function in pigs carrying a dominant mutation in type X collagen". Mamm. Genome. 11 (12): 1087–92. doi:10.1007/s003350010212. PMID 11130976.

[gidney-19] Gidney, Louisa (May–June 1019). "Earliest Archaeological Evidence of the Ancon Mutation in Sheep from Leicester, UK". International Journal of Osteoarchaeology. John Wiley and Son. 15 (27): 318–321. doi:10.1002/oa.872. ISSN 1099-1212.

匿名

検索

案内

案内

achondroplastic